IONIS-DNM2-2.5Rx

N/A

Report date: 2022/11/25 17:43:13
NME

Base Information

Drug NameIONIS-DNM2-2.5Rx
Drug Alias NameDyn-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionDynamin 2 inhibitors
TargetsDynamin 2
Therapy Area/IndicationsMyopathies, Structural, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNetherlandsDenmark +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDynacure SasNippon Shinyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsMyopathies, Structural, Congenital

Other Information

ATC CodeN/A
Related LinksN/A